Novel |
BOD1L1 |
biorientation of chromosomes in cell division 1 like 1 |
- Formation of WDR5-containing histone-modifying complexes
|
|
|
Novel |
CLNK |
cytokine dependent hematopoietic cell linker |
|
|
|
Novel |
HTRA3 |
HtrA serine peptidase 3 |
|
|
|
Novel |
MKX |
mohawk homeobox |
|
|
|
Novel |
MRFAP1L1 |
Morf4 family associated protein 1 like 1 |
|
|
|
Novel |
NKX2-1 |
NK2 homeobox 1 |
|
|
- Choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
Novel |
TADA2B |
transcriptional adaptor 2B |
- HATs acetylate histones
- Ub-specific processing proteases
|
|
|
Novel |
TRMT44 |
tRNA methyltransferase 44 homolog |
- tRNA modification in the nucleus and cytosol
|
|
|
|
ARK2N |
arkadia (RNF111) N-terminal like PKA signaling regulator 2N |
|
|
|
|
BLK |
BLK proto-oncogene, Src family tyrosine kinase |
- RUNX1 regulates transcription of genes involved in BCR signaling
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Fostamatinib
- Zanubrutinib
|
- Maturity onset diabetes of the young (MODY)
|
|
CBX8 |
chromobox 8 |
- Oxidative Stress Induced Senescence
- SUMOylation of DNA damage response and repair proteins
- SUMOylation of transcription cofactors
- SUMOylation of chromatin organization proteins
- SUMOylation of RNA binding proteins
- SUMOylation of DNA methylation proteins
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
|
|
|
|
CHRM3 |
cholinergic receptor muscarinic 3 |
- Muscarinic acetylcholine receptors
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
|
- Cevimeline
- Tramadol
- Succinylcholine
- Trospium
- Ziprasidone
- Disopyramide
- Amitriptyline
- Ipratropium
- Olanzapine
- Metixene
- Terfenadine
- Clozapine
- Doxylamine
- Trihexyphenidyl
- Oxyphencyclimine
- Procyclidine
- Loxapine
- Carbamoylcholine
- Hyoscyamine
- Cyproheptadine
- Meperidine
- Imipramine
- Methscopolamine bromide
- Chlorpromazine
- Darifenacin
- Haloperidol
- Tridihexethyl
- Anisotropine methylbromide
- Nortriptyline
- Amoxapine
- Cinnarizine
- Atropine
- Thiopental
- Nicardipine
- Paroxetine
- Homatropine methylbromide
- Trimipramine
- Scopolamine
- Benzquinamide
- Propiomazine
- Dicyclomine
- Tropicamide
- Brompheniramine
- Maprotiline
- Methantheline
- Glycopyrronium
- Bethanechol
- Tolterodine
- Oxybutynin
- Promethazine
- Pilocarpine
- Doxepin
- Desipramine
- Ketamine
- Quetiapine
- Mivacurium
- Diphenidol
- Aripiprazole
- Chlorprothixene
- Pancuronium
- Pipecuronium
- Methotrimeprazine
- Tiotropium
- Solifenacin
- Isopropamide
- Acetylcholine
- Arecoline
- Mepenzolate
- ALKS 27
- Pizotifen
- Fesoterodine
- Methacholine
- Hexocyclium
- Aclidinium
- Umeclidinium
- Trimebutine
- Dosulepin
- Viloxazine
- Etoperidone
- Imidafenacin
- Butylscopolamine
- Homatropine
- Thonzylamine
- Revefenacin
- Propiverine
- Rociverine
- Diphemanil
- Aripiprazole lauroxil
|
|
|
DDX6 |
DEAD-box helicase 6 |
- mRNA decay by 5' to 3' exoribonuclease
|
|
|
|
DSCR9 |
Down syndrome critical region 9 |
|
|
|
|
ENKD1 |
enkurin domain containing 1 |
|
|
|
|
FXR1 |
FMR1 autosomal homolog 1 |
- Signaling by BRAF and RAF1 fusions
|
|
|
|
GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- Acamprosate
- Progabide
- Taurine
- gamma-Aminobutyric acid
- SGS-742
- Tezampanel
- Arbaclofen
- Arbaclofen Placarbil
- Sodium oxybate
- L-Baclofen
|
|
|
IL16 |
interleukin 16 |
- Other interleukin signaling
|
|
|
|
JAK1 |
Janus kinase 1 |
- Interleukin-6 signaling
- Interleukin-6 signaling
- MAPK3 (ERK1) activation
- MAPK1 (ERK2) activation
- ISG15 antiviral mechanism
- Interleukin-7 signaling
- Interleukin-7 signaling
- Other interleukin signaling
- RAF/MAP kinase cascade
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- IL-6-type cytokine receptor ligand interactions
- Interferon gamma signaling
- Regulation of IFNG signaling
- Regulation of IFNG signaling
- Interleukin-20 family signaling
- Interleukin-15 signaling
- Interleukin-15 signaling
- Interleukin-35 Signalling
- Interleukin-9 signaling
- Interleukin-2 signaling
- Interleukin-12 signaling
- Interleukin-12 signaling
- Interleukin-27 signaling
- Interleukin-27 signaling
- Interleukin-21 signaling
- Interferon alpha/beta signaling
- Interleukin receptor SHC signaling
- Regulation of IFNA/IFNB signaling
- Regulation of IFNA/IFNB signaling
- Signaling by CSF3 (G-CSF)
- Signaling by CSF3 (G-CSF)
- Potential therapeutics for SARS
- Inactivation of CSF3 (G-CSF) signaling
- Inactivation of CSF3 (G-CSF) signaling
- SARS-CoV-2 activates/modulates innate and adaptive immune responses
- IFNG signaling activates MAPKs
- Evasion by RSV of host interferon responses
- PD-L1(CD274) glycosylation and translocation to plasma membrane
|
- Myricetin
- 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
- Ruxolitinib
- Tofacitinib
- Baricitinib
- Fostamatinib
- Fedratinib
- Filgotinib
- Abrocitinib
- Upadacitinib
- Pralsetinib
- Ivarmacitinib
|
|
|
MCRS1 |
microspherule protein 1 |
- HATs acetylate histones
- UCH proteinases
- DNA Damage Recognition in GG-NER
- Formation of WDR5-containing histone-modifying complexes
|
|
|